Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).
about
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentThe role of the immune system in non-small cell lung carcinoma and potential for therapeutic interventionTrends and advances in tumor immunology and lung cancer immunotherapyEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisThe Treg/Th17 paradigm in lung cancerClinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma.Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma.The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Further study of circulating IgG antibodies to CD25-derived peptide antigens in nonsmall cell lung cancerShorter telomere length of T-cells in peripheral blood of patients with lung cancer.Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancerClinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.Expression of CTLA-4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma.Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans.Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer PatientsExploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer.The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.Mechanisms of immune response regulation in lung cancer.Regulatory T cells and potential inmmunotherapeutic targets in lung cancer.Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.Immune Therapy.Combination radiotherapy and cantharidin inhibits lung cancer growth through altering tumor infiltrating lymphocytes.Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.Quantitative analysis and clonal characterization of T-cell receptor β repertoires in patients with advanced non-small cell lung cancer treated with cancer vaccine.Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer.The role and significance of VEGFR2+ regulatory T cells in tumor immunityPrognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.LAP TGF-Beta Subset of CD4(+)CD25(+)CD127(-) Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients.Immune checkpoint inhibitors in cancer therapy.Study of circulating antibodies against CD25 and FOXP3 in breast cancer.Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-Small-Cell Lung Cancer.Innate and acquired immune surveillance in the postdissemination phase of metastasis.Intracellular Flow Cytometry Improvements in Clinical Studies.Elevated Regulatory T Cell Levels in Glaucoma Patients in Comparison to Healthy Controls.
P2860
Q26738359-0FF024A7-B295-4D30-B827-B72EA697EBE8Q27024781-D9C2C895-A365-42EF-BB2F-4B5367FC9BCDQ28067674-1A17B905-D13D-4F48-B122-FD21B24B5B38Q28069422-DFC902F7-F0AE-434B-A52E-A8289D0F531FQ33608606-E836D917-E9A8-40A0-A455-8FBB4800F8AAQ33657979-4E0A6FF0-40FE-4BEF-8C34-7968CEB7FA4FQ34502899-0C6032EB-F06A-45EF-B3E4-ACB12FC8935FQ34646640-2D813BC9-86E8-48C0-8469-69CB32BCAB9AQ35931188-F4C596E1-53AA-4665-B167-3B4E90ABD411Q36283876-B7D6EA7D-3E03-41BE-8A2C-F0EFA91CF01EQ36546997-6CDCDD6E-5088-4668-8173-93CFD569542DQ36694379-ACDED6F0-B932-4F00-8353-9B5B2F1EC10AQ36891539-85AB5A68-6565-488B-95DA-9AFCFB26D34CQ36963287-BA19CE3D-2813-476A-B4F6-CB6032A9A4E3Q37392642-4A430621-133B-47CF-A3B5-0FF5C969536FQ37601910-ADFE1650-9D99-4E72-8C39-FF9397BD669DQ37614743-CC8B0995-91CE-4353-B03E-735E1C0E87EDQ37639474-E47B2C57-D1C6-4D92-B2B8-8437875FBBD7Q38246950-C6CA3079-84C2-4ACC-B559-ECED92E5117BQ38296670-A686B167-1AD3-4130-899F-C9ABCE205981Q38390097-9DE7F57C-ACBB-4AAF-80BA-D69F2C35B332Q38473314-6C110352-40C6-485B-86BC-AE845DA161D4Q38621446-033A6928-4737-42EC-A5C0-A6CEBAFBB465Q38669273-E8C52B23-9B0E-4C72-981B-8238AEF2FEBFQ38684656-66CA7DFA-71D2-4DBF-985F-183187B45FAEQ38784372-7AEE93A9-C94E-4B8C-9D4F-8938C474A306Q39022564-9112CFA4-93AD-4012-953C-52202E86B7E6Q40832649-75CF6EA4-93C4-44A6-99A2-CFA9EBC543A0Q40978230-21A9E10B-13AB-40BA-9DB9-89BE28131ED2Q41092061-FA3826CD-4C94-4146-83D1-DBBE7B5FD1DBQ41472493-C4FFA8B5-32EB-4E2F-A1B9-104FB8E488E1Q41499942-55CE8E83-5509-4C24-9BE8-913FF2EE7A43Q42352636-ED7FBDB3-B099-4ECF-9679-85943627C6EDQ43184376-15758FCC-7F99-432E-B272-48AA118A0145Q45871487-FB6F2159-4214-42BA-A26B-1408882F4F4EQ45935803-5F6BB075-15E1-4D6B-99F7-3F55469B58FCQ49778589-C22B30CE-582E-4F5F-94EF-C8375EFE216AQ50048813-ECC104C2-1234-4E0F-B254-1518DD58ABD8Q51075813-F2B0CBEB-B5AF-4128-8C38-C834FB29AC65Q51410147-819F36F7-7C55-4171-8833-DC3CC8405844
P2860
Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Increase of regulatory T cells ...... mall cell lung cancer (NSCLC).
@ast
Increase of regulatory T cells ...... mall cell lung cancer (NSCLC).
@en
Increase of regulatory T cells ...... ith non-small cell lung cancer
@nl
type
label
Increase of regulatory T cells ...... mall cell lung cancer (NSCLC).
@ast
Increase of regulatory T cells ...... mall cell lung cancer (NSCLC).
@en
Increase of regulatory T cells ...... ith non-small cell lung cancer
@nl
prefLabel
Increase of regulatory T cells ...... mall cell lung cancer (NSCLC).
@ast
Increase of regulatory T cells ...... mall cell lung cancer (NSCLC).
@en
Increase of regulatory T cells ...... ith non-small cell lung cancer
@nl
P2093
P50
P1433
P1476
Increase of regulatory T cells ...... small cell lung cancer (NSCLC)
@en
P2093
Abbas Ghaderi
Davar Amani
Shayesteh Mofakhami Mehrabadi
Zahra Mojtahedi
P304
P356
10.1016/J.LUNGCAN.2012.04.011
P577
2012-05-17T00:00:00Z